ArticleAmerican journal of blood research2021

Long term outcome of a patient with relapsed refractory early thymic precursor acute lymphoblastic leukemia treated with daratumumab.

Sachin Punatar et al.PubMed ↗Full text ↗

No numbers read from the abstract.